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Abstract
First lineage specification in the mammalian embryo leads to formation of the inner cell mass (ICM) and trophectoderm (TE),
which respectively give rise to embryonic and extraembryonic tissues. We show here that this first differentiation event is
accompanied by asymmetric distribution of trimethylated histone H3 lysine 27 (H3K27me3) on promoters of signaling and
developmentally-regulated genes in the mouse ICM and TE. A genome-wide survey of promoter occupancy by H3K4me3
and H3K27me3 indicates that both compartments harbor promoters enriched in either modification, and promoters co-
enriched in trimethylated H3K4 and H3K27 linked to developmental and signaling functions. The majority of H3K4/K27me3
co-enriched promoters are distinct between the two lineages, primarily due to differences in the distribution of H3K27me3.
Derivation of embryonic stem cells leads to significant losses and gains of H3K4/K27me3 co-enriched promoters relative to
the ICM, with distinct contributions of (de)methylation events on K4 and K27. Our results show histone trimethylation
asymmetry on promoters in the first two developmental lineages, and highlight an epigenetic skewing associated with
embryonic stem cell derivation.
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Introduction
Embryo development is regulated by the acquisition of distinct
programs of gene expression as cells differentiate. Blastomere
compaction and polarization at the 8–16 cell stage in the mouse
embryo define inner and outer cells and provide the first sign of
lineage specification. Inner cells give rise to the inner cell mass
(ICM) which differentiates into embryonic lineages, while outer
cells give rise to the trophectoderm (TE) which gives rise
extraembryonic tissues [1]. Transcriptional programs regulated
by gradually exclusive Cdx2, Eomes and Elf5 expression in the
trophectoderm and Oct4, Nanog and Sox2 expression in the ICM
underline this first lineage specification [2,3]. Embryonic and
extraembryonic lineages display differences in DNA methylation,
with the placenta being hypomethylated, a condition reflecting the
hypomethylated state of the TE relative to the ICM [2,4]. In
addition, immunolabeling studies have shown that histone H3
lysine 27 trimethylation (H3K27me3), a histone modification
commonly associated with transcriptionally repressed genes, is
more abundant in the ICM than in the TE [5]. This asymmetry in
DNA and H3 methylation patterns reflects distinct gene
expression programs and is believed to be important for lineage
commitment [2,4,5].
Similarly to the ICM from which they are derived, embryonic
stem cells (ESCs) are pluripotent; however unlike ICM cells which
differentiate, ESCs can self-renew without compromising pluripo-
tency [6]. Mouse ESCs display similarities with ICM cells, cells
of the epiblast of early post-implantation embryos and with
primordial germ cells, and like ICM cells, they are heterogeneous
in their pattern of protein and gene expression [7,8]. Unlike ICM
cells however, ESCs are adapted to culture; protein expression is
also interchangeable among cells in a given ESC culture and is
associated with dynamic changes in histone modifications [7].
Thus, ESCs are likely to epigenetically diverge from the ICM and
display complex histone modification patterns.
Genome-wide maps of posttranslational histone modifications,
DNA methylation, and Trithorax and Polycomb target genes have
unraveled chromatin states of pluripotency in ESCs [9–16]. These
studies show that whereas H3K4me3 marks many promoters
including those of highly expressed genes, H3K27me3 is enriched
on promoters of inactive or weakly expressed genes. Undifferen-
tiated cells also contain chromatin domains co-enriched in
H3K4me3 and H3K27me3, which encompass genes that are
transcriptionally halted or expressed at low level [9,10]. Upon
differentiation, these genes undergo demethylation on H3K27 and
retain H3K4me3 when activated, or retain H3K27me3 and lose
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9150trimethylation on H3K4 when shut down [10,11]. Co-enrichment
of H3K4me3 and H3K27me3 on promoters has thus been
proposed to constitute a mark of priming for transcriptional
activation in undifferentiated cells. A similar picture emerges for
lineage-specification genes in hematopoietic and mesenchymal
progenitor cells [17,18].
Except for information on a handful of genes [19,20], virtually
nothing is known on the genomic distribution of post-translation-
ally modified histones in preimplantation embryos. This is pre-
sumably due to a lack of suitable tools. Genome-scale studies of
mammalian embryos have been hampered by a requirement for
large cell numbers for chromatin immunoprecipitation (ChIP), a
technique widely used to map histone modifications and protein
binding on the genome in vivo [21]. Here, we applied our micro
(m)ChIP assay for small cell numbers [22,23] to map promoter
occupancy of trimethylated H3K4 and H3K27 in the ICM and
TE, and assess the dynamics of these modifications after derivation
of ESCs.
Results
Profiling of H3K4 and H3K27 Trimethylation on
Promoters in the ICM and TE
Mouse blastocysts cultured in vitro from the two-cell stage
contain .60 cells, including ,20 in the ICM and the rest in the
TE. We purified TEs by bisection and ICMs by dissection
followed by immunosurgery (Figure 1A). Isolated ICMs and TEs
were viable because they reformed new blastocysts and tropho-
blastic vesicles, respectively (Figure S1). ICM and TE chromatin
was subjected to triplicate H3K4me3 and H3K27me3 mChIPs
and ChIP DNA was hybridized to microarrays tiling 22t o
+0.5 kb relative to the transcription start site (TSS) of ,27,000
promoters, including 19,489 RefSeq promoters. Reproducibility of
mChIP-chip relative to Q
2ChIP-chip (from 100,000 cells) and
between mChIP-chip replicates has previously been reported [23].
Reproducibility was further shown here by two-dimensional
scatter plots of MaxTen values for H3K4me3 and H3K27me3
(Figure S2A,B), and by the similarity of average enrichment
profiles on metagenes (Figure S2C) and of promoter-specific
enrichment patterns (Figure S2D and Figure S3).
Two-dimensional scatter plots of MaxTen values for H3K4me3
vs.H3K27me3log2 signalintensitiesforallRefSeqpromotersinthe
ICM and TE showed distinct enrichment patterns in each lineage
(Figure 1B,C). Using a peak detection algorithm with a false
discovery rate (FDR) of #0.1 for identification of enrichment in
either modification, we showed that the ICM and TE contain a
similar number of H3K4me3-enriched promoters, while the ICM
harbors more promoters enriched in H3K27me3 than the TE
(Figure 1D). We also identified in both lineages promoters co-
enriched in H3K4me3 and H3K27me3 (referred to hereafter as
H3K4/K27me3 promoters; Figure 1D, intersects). These made up
,10% of all peak-containing promoters in the ICM and TE but
were nevertheless 2.5 times more frequent in the ICM than in the
TE. Thus, H3K4/K27me3 promoters constitute a minor yet
significant proportion of promoters in both lineages. These results
show a predominance of promoters enriched in H3K4me3 over
H3K27me3 in both the ICM and TE; this observation was not
unexpected as the correlation of H3K27me3 with promoters has
been shown to be in general rather low in other cell types [15,24].
Additionally, the ICM harbors more H3K27me3 promoters than
the TE, corroborating on the promoter scale the global enrichment
of H3K27me3 in the ICM reported by immunolabeling [5].
To determine the extent of overlap of H3K4me3 and H3K27me3
in the average H3K4/K27me3 promoter, we computed a metagene
profile for each modification over the tiled regions (Figure 1E). In
both the ICM and TE, H3K4me3 displayed a wide enrichment
over 21,800 to 2500 bp relative to the TSS, followed by a dip
immediately upstream of the TSS, suggestive of displaced or
unstable nucleosomes at the TSS [25,26]. H3K27me3 overlapped
largely with H3K4me3 but declined more gradually toward the
TSS (Figure 1E, left panels). In concordance with expression status,
the seemingly ‘nucleosome-depleted’ region delineated by the
H3K4me3 profile in H3K4me3 promoters was more pronounced
than that of H3K4/K27me3 promoters (Figure 1E). This suggests
that H3K4me3 distribution is influenced by co-enrichment of
H3K27me3.
Gene ontology (GO) analysis indicated that in both the ICM
and TE, H3K4me3 and H3K27me3 genes were enriched in
housekeeping and signaling processes, respectively, wheras
H3K4/K27me3 genes were predominantly linked to signaling,
development/differentiation and transcription regulation func-
tions (Figure 2A; Table S1). These functional categories were
corroborated by the analysis of all GO terms identified among
genes with promoters co-occupied by trimethylated H3K4 and
H3K27 (Figure 2B; Table S2). These functional groups are
remarkably similar to those reported in ESCs (see below), arguing
that H3K4 and H3K27 trimethylation highlights similar sets
of functions in embryonic cells, cultured or in vivo.F u n c t i o n a l
categories linked to H3K4 and H3K27 trimethylation are thus
similar in the ICM and TE, although many genes carrying
these modifications are distinct. Trimethylation of H3K4 and
H3K27, therefore, delineates a cell identity profile in the ICM
and TE.
H3K4me3 and H3K27me3 Enrichment on Promoters of
Genes Linked to Embryonic and Extraembryonic
Development in the ICM and TE
We next examined H3K4me3 and H3K27me3 profiles on
promoters of genes reported to be expressed in the ICM and/or in
the TE (Figure 3A,B) [1,27]. Among genes expressed in the ICM,
Oct4, Sox2, Lifr, Rex1, Klf4 and Stella were either enriched in
H3K4me3 relative to genome-average (Oct4, Sox2, Lifr, Klf4)o r
occupied by H3K4me3 at near genome-average level (Rex1, Stella).
These promoters were either strongly hypo-trimethylated on
H3K27 (Sox2, Rex1, Klf4, Stella) or harbored low levels of
H3K27me3 (Oct4, Lifr). This was consistent with expression of
these genes in the ICM, and notably with Oct4 expression in a
subpopulationofcellswithinthe ICM[27].Inthe TE,some ofthese
genes were also enriched in H3K4me3 (Oct4, Rex1, Klf4, Stella) with
enrichment in or low level H3K27me3, while others (Sox2, Lifr)
harbored no H3K4me3 but were enriched in H3K27me3. These
observations illustrate, therefore, similar H3K4 or H3K27
trimethylation profiles on a subset of genes (e.g., Oct4, Rex1, Klf4
and Stella) in both the ICM and TE despite their distinct expression
pattern in these compartments. Others, such as Sox2 and Lifr,
harbor H3K4me3 and H4K27me3 profiles that would be
anticipated from their expression patterns.
Among genes expressed in the TE, Cdx2, Tpbpa and Eomes were
occupied with (Cdx2, Eomes) or enriched in (Tpbpa) H3K27me3 in
the ICM, and impoverished in H3K27me3 (Cdx2, Eomes)o r
occupied at genome-average level by H3K27me3 (Tpbpa)i nt h e
TE. These genes however showed no difference in H3K4me3
enrichment between the two compartments, consistent with
observations that H3K4me3 can also occupy inactive promoters
[28]. Lastly among genes expressed in both ICM and TE, Hhex,
Cdh1 and Tead4 were enriched in H3K4me3 with little or no
H3K27me3, suggesting mosaic expression in both lineages. mChIP-
qPCR data corroborated mChIP-chip results and in addition
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PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9150Figure 1. Distribution of H3K4me3, H3K27me3 and H3K4/K27me3 promoters in the ICM and TE. (A) Isolation of ICMs (white arrow) and TEs
(black arrow) from E4 blastocysts by microdissection (left panels), followed by immunosurgery of the ICM/TE halves to purify the ICM (large arrow). (B)
2-D scatter plots of averaged MaxTen values for H3K4me3 vs. H3K27me3 log2 signal intensities in the ICM (left) and TE (right). Data points were colored
to indicate classification according to the peak calling algorithm to show H3K4me3-enriched promoters (green), H3K27me3-enriched promoters (red)
andpromotersco-enrichedin H3K4me3 andH3K27me3(blue). (C)H3K4me3 andH3K27me3 enrichment profiles on indicated promoters in the ICM and
TE.Dataareexpressedaslog2ChIP/Inputratios.(D)VenndiagramanalysisofH3K4me3andH3K27me3promotersinICMandTE.(E)Averagedistribution
of H3K4me3 and H3K27me3 on H3K4/K27me3, H3K4me3 and H3K27me3 promoters, relative to the position of the TSS (red bar).
doi:10.1371/journal.pone.0009150.g001
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H3K4me3 only in the ICM, and H3K27me3 with reduced
H3K4me3 in the TE, as expected from its expression pattern in
these compartments [1](Figure 3C). Weinfer from theseresultsthat
promoter enrichment in trimethylated H3K4 or H3K27 does not
always correlate, in the embryo, with gene expression or repression,
respectively (see also ref. [20]).
To examine this aspect further, we analyzed 15,941 cDNAs
included in a published Affymetrix gene expression data set for
twenty single ICM cells (GEO series GSE4307) [27]. Each probe
on that array had a present/absent call and an expression index
reported by DNA Chip Analyzer [29]. For each probe on the
Affymetrix array, we derived a present/absent call by scoring
‘present’ if a signal was detected in ten or more of the twenty cell
samples analyzed, in agreement with the method used to collapse
replicates by DNA Chip Analyzer [29]. We found that in the ICM
76% of H3K4me3 promoters, 19% of H3K27me3 promoters and
51% of H3K4/K27me3 promoters were associated with expressed
genes (Figure 3D). GO terms for all these expressed genes were
linked to housekeeping functions regardless of H3K4 or H3K27
methylation state (Tables S3 and S4). These results imply that
most H3K4/K27me3 genes encoding signaling and developmen-
tal functions in the ICM are in an inactive state. Nonetheless,
detection of H3K27me3 on a subset of expressed genes in the ICM
also suggests that these genes are not expressed in all cells of the
ICM, in agreement with the mosaic expression of many genes in
the ICM [1,27]. Alternatively, some level of H3K27 trimethylation
may be compatible with a transcriptionally active state [16].
Figure 2. Genes with promoters enriched in H3K4me3 and/or H3K27me3 are associated with distinct functional categories. (A) GO
term enrichment of genes containing H3K4me3, H3K27me3 or H3K4/K27me3 promoters in the ICM and TE. The twelve most significant GO terms are
shown as a function of significance (P-value). (B) GO term representation of all genes containing H3K4/K27me3 promoters in the ICM and TE.
doi:10.1371/journal.pone.0009150.g002
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between the ICM and the TE
We next examined the extent of epigenetic overlap between the
ICM and TE. Two-dimensional scatter plots of MaxTen values from
H4K3me3 and H3K27me3 signal intensities in the ICM vs. TE
(Figure 4A), together with peak identification (Figure 4B) showed
greater overlap of H3K4me3 than H3K27me3 between the two
lineages. Nearly 80% of H3K4me3 promoters in the ICM or TE were
also enriched in H3K4me3 in the other compartment (Figure 4C).
However, we found a lower proportion of H3K27me3 promoters
(34%) and of H3K4/K27me3 promoters (22%) in the ICM that also
contained these marks in the TE (Figure 4C). Therefore, in the
blastocyst, H3K4me3 is largely conserved on promoters in both
lineages, whereas there is significant asymmetry in the distribution of
H3K27me3. This largely contributes to the asymmetry of H3K4/
K27me3 promoter distribution between the ICM and TE.
In female mouse embryos, H3K27me3 has been shown to be
enriched on the inactive X chromosome in the TE [5].
Figure 3. H3K4me3 and H3K27me3 enrichment profiles on genes expressed in the ICM and the TE. (A) mChIP-chip data of H3K4me3 and
H3K27me3 enrichment profiles on promoters of indicated genes in the ICM and TE (log2 ChIP/input ratios). (B) Expression scoring and pattern of each
gene examined in (A) in the ICM (Var., variable expression level; Const., consistent expression pattern). Data were extracted from published Affymetrix
data [27]. (C) mChIP-qPCR analysis of H3K4me3 and H3K27me3 enrichment on the promoter of Oct4, Nanog and Hhex in the ICM and TE. (D)
Percentage of expressed genes with promoters enriched in H3K4me3, H3K4/K27me3 or H3K27me3. Data were extracted from the Affymetrix dataset
referred to in (B).
doi:10.1371/journal.pone.0009150.g003
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examined in our study was presumably equal, and although active
and inactive X could not be distinguished on the array, we found
in the TE a 3-fold enrichment of X-linked H3K27me3 promoters
relative to the frequency of H3K27me3 promoters in the rest of
the genome (data not shown). X-linked genes enriched in
H3K27me3 in the TE are listed in Table S5.
Dynamic Changes in H3K4 and H3K27 Methylation
Patterns after Derivation of Embryonic Stem Cells
To identify H3K4 and H3K27 methylation changes associated
with the establishment of ESCs, we derived ESCs from the ICM of
B6D2F2 blastocysts (the strain examined here) and mapped
H3K4me3 and H3K27me3 promoter enrichment profile. mChIP-
chip from 1,000 ESCs notably revealed H3K4/H3K27me3 co-
enrichment of the developmentally regulated Hoxb locus (Figure
S4A) and enrichment of pluripotency genes in H3K4me3 with no
or little H3K27me3 (Figure S4B). GO term enrichment analysis
indicates that H3K4me3 enrichment was linked to housekeeping
functions, whereas H3K27me3 and H3K4/K27me3 were associ-
ated with developmental and differentiation functions (Figure
S4C; Table S6). These results validate mChIP-chip in relation to
published data for ESCs [10,11,15,16,28]. Moreover, additional
validation of our mChIP-chip approach was provided by cross-
examination of H3K4me3- or H3K27me3 enriched genes
identified in ESCs in our study with those identified by ChIP-
sequencing in mouse ESCs [11]. This revealed that 76% and 56%
of H3K4me3 and H3K27me3 genes, respectively, identified here
were also found with these respective modifications by ChIP-
sequencing [11] (data not shown). These proportions are con-
sistent with overlaps between earlier published genome-wide
investigations [11,16,28,30].
We next examined the extent of conservation of H3K4 and
H3K27 trimethylation states between ICMs and ESCs (Figure 5A).
Approximately 30% of H3K4me3 promoters and 20% of
H3K27me3 or H3K4/K27me3 promoters in the ICM retained
these marks in ESCs (Figure 5B, red bars). Thus most H3K4me3
and H3K27me3 promoters in the ICM lose trimethylation on K4
or K27, completely or to a level below peak detection threshold
(Figure 5B, gray bars, left 3 columns). Similarly, ,80% of H3K4/
K27me3 promoters in the ICM harbored one or the other mark in
ESCs by losing trimethylation on K4 or K27 or reducing levels
thereof. In ESCs, over 40% of H3K4me3 promoters and over
80% of H3K27me3 and H3K4/K27me3 promoters gain these
marks (Figure 5B, gray bars, right 3 columns). Consistent with our
earlier findings, GO terms enriched and for all genes associated
with common H3K4/K27me3 targets in the ICM and ESCs are
involved in development and differentiation (32%), signal
transduction (17%) and transcription regulation (16%) (Table
S7; Figure 5C).
Figure 4. H3K27me3 is asymmetrically distributed in the ICM and TE. (A) 2-D scatter plots of averaged MaxTen values for H3K4me3 and
H3K27me3 log2 signal intensities in ICM vs. TE. Data points were colored to indicate classification according to the peak calling algorithm to show
H3K4me3- or H3K27me3-enriched promoters in all ChIP replicates in the TE (green), the ICM (purple) and common to both lineages (blue). (B) Venn
diagram analysis of H3K4me3, H3K27me3 and H3K4/K27me3 promoters in ICM and TE. (C) Percentages of H3K4me3, H3K27me3 and H3K4/K27me3
promoters shared between ICM and TE, or unique to either lineage.
doi:10.1371/journal.pone.0009150.g004
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different from ICM cells. Loss of H3K4/K27me3 promoters upon
derivation of ESCs does not result from an overt loss of
methylation on one lysine or the other, but from a similar
contribution of methylation loss on K4 and K27. In contrast, gain
of trimethylation on H3K27 is more dynamic in ESCs than
changes in H3K4 methylation. Further, the number of H3K4/
K27me3 promoters in ESCs is greater than in the ICM, and the
majority of these appear as ‘de novo’ H3K4/K27me3 promoters.
The different epigenetic patterns of ICM cells and ESCs prompted
the determination of whether ICM and ES cells had more common
bound targets than ICM and TE or TE and ES cells. Our data show
that ICM and ESCs have a number of common H3K4/K27me3
targets (n=105) similar to ICM and TE cells (n=108); however,
ESCs and TE cells share fewer common targets (n=37, P=0.013,
Fisher’s test; Figure 5D). ICM and ES cells seem therefore to be more
closely epigenetically related to each another than ES and TE cells, an
observation in line with the absence of similarity of mouse ESCs with
cells of the TE [7]. There was nevertheless only minor overlap of
targets between ICM, TE and ES cells (Figure 5D), indicating that
these cell types are largely epigenetically distinct.
H3K4/K27me3 ICM-specific genes that lose methylation on
either K4, K27 or both in ESCs, and those genes gaining H3K4/
K27me3 in ESCs are listed with their GO terms in Table S8. We
found for instance that H3K4/K27me3-marked telomerase (Tert)
loses H3K27me3 to retain H3K4me3 in ESCs, consistent with
expression of the gene in these cells. Similarly, several DNA repair
genes (Lig1, Poln, Gtf2h5) also lose the H3K4/K27me3 double
mark of the ICM to retain H3K4me3 in ESCs, suggesting an
involvement of these genes in maintaining genomic integrity in
rapidly dividing cells. We also found that genes involved in ICM
proliferation, blastocyst development and implantation (Luzp5,
Surb7, Dnaja3, Grn, Egln1) are marked by H3K4/K27me3 only in
the ICM but not in the TE (Table S9), suggesting transcriptional
posing of these genes by H3K27 trimethylation until their
activation is required for development. Remarkably, all these
genes lose methylation on both H3K4 and H3K27 in ESCs.
Genes gaining H3K4/K27me3 in ESCs (Table S8) included the
TE markers Cdx2 and Eomes, and the Hoxb locus (implicated in
anterior-posterior patterning), which is predominantly enriched in
H3K4me3 only in the ICM. It emerges from these data that
establishment of ESCs is associated with epigenetic changes
reflecting a loss of function pertaining to early embryo develop-
ment such as blastocyst development or patterning. These changes
are paralleled by marked H3K4 and H3K27 methylation
dynamics for a large number of genes implicated in several signal
Figure 5. Divergence of H3K4me3 and H3K27me3 enrichment profiles between ICM and ESCs. (A) Venn diagram analysis of H3K4me3,
H3K27me3 and H3K4/K27me3 promoters retaining and losing these marks after derivation of ESCs. (B) Percentages of promoters enriched in
H3K4me3, H3K27me3 or both marks in the ICM and ESCs. (C) GO term representation of all H3K4/K27me3 genes identified in both the ICM and ESCs.
(D) Venn diagram analysis of H3K4/K27me3 promoters in the ICM, TE and ESCs.
doi:10.1371/journal.pone.0009150.g005
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9150transduction pathways. These changes are likely to reflect the
nature of functional changes taking place in ICM cells upon
derivation of ESCs.
Discussion
Mapping of Histone Modifications in Preimplantation
Mouse Embryos
We have interrogated by ChIP-on-chip sites of trimethylated
H3K4 and H3K27 on RefSeq promoters in the ICM and TE, the
first two distinct developmental lineages. This is to our knowledge
the first genome-scale epigenetic profiling of preimplantation
mammalian embryos, extending recent single gene-level studies
[19,20]. We reveal histone methylation asymmetry between the
ICM and TE primarily caused by differences in promoter
distribution of H3K27me3, and show that derivation of ESCs
results in broad methylation changes on H3K4 and H3K27
relative to the ICM.
Co-enrichment and overlap of H3K4me3 and H3K27me3 on
promoters suggests the existence of promoters harboring both
marks in the embryo, adding to view that such promoters may
exist in ESCs [9,10,16], progenitor cells [11,15,17,18] and
differentiated cells [24]. Overlapping of average profiles does not
mean, however, that H3K4me3 and H3K27me3 peaks overlap on
all promoters. Distribution of H3K4 and H3K27 methylation
relative to each other [28] may impact on the activity of the target
promoter. For instance, the depth of the H3K4me3 dip detected at
the metagene level at the TSS on H3K4me3 promoters is not as
pronounced among H3K4/K27me3 promoters. This suggests two
subpopulations of such promoters: one with an H3K27me3 peak
upstream of and non-overlapping the H3K4me3 peak, and one
subpopulation with overlapping H3K4me3 and H3K27me3 peaks
and no nucleosome-depleted region. On these promoters, the
profile of H3K4me3 may be modulated by co-enrichment of
repressive H3K27me3, which alters chromatin organization.
Co-detection of H3K4me3 and H3K27me3 in ICM, TE and
ES cells may also reflect different epigenetic states in subpopula-
tions of cells expressing different genes [7,8,27]. Heterogeneity in
protein and gene expression is a hallmark of ESCs [7].
Remarkably, these expression states display a fluctuating equilib-
rium which parallels reversible histone modifications [7]. The
ICM also contains a heterogeneous population of cells [1],
exemplified by mutually exclusive expression of Nanog in the
epiblast and Gata6 in the primitive endoderm [31]. Sorting
expression profiles of single ICM cells [27] based on Nanog or Gata6
mRNA levels indicates that even Nanog-o rGata6-expressing cells
show variations in the nature of their transcripts [27]. These
subpopulations therefore likely harbor different combinations of
epigenetic marks on several loci.
Examples of trimethylated H3K4 and H3K27 profiles in the ICM
and TE shown in Figure 3A are consistent with H3K4me3 enrich-
ment or occupancy on most promoters irrespective of expression
status [11,28]. Moreover, extending recent carrier-ChIP data in
cultured preimplantation mouse embryos [20], we find that there
is not necessarily a robust correlation between H3K4me3 or
H3K27me3 occupancy or enrichment and gene expression in the
ICM or TE; this is particularly clear for H3K27me3. Accordingly,
changes in gene expression during tissue regeneration cannot entirely
be explained by these marks alone [32]. It has also been shown that
differentiation can induce high levels of histone acetylation which
may override the repressive effect of H3K27me3 [33].
Our data also infer that some genes may be regulated differently
by, or independently of, occupancy levels of trimethylated H3K4 or
H3K27 in the ICM and TE. To what extent these ‘inconsistencies’
reflect the in vivo situation in the embryo or in vitro embryo culture
conditions remains to be examined. An additional component
adding to the complexity of interpretation of H3K27me3
enrichment in particular is the newly discovered role of the
H3K27me3 histone methyltransferase Ezh2 as a transcriptional
activator on cell cycle- genes in cancer cells [34]. It is therefore
possible that detection of H3K27me3 on specific loci may have a
function other than transcriptional repression. One should also
mention that a log2 ChIP/input probe signal of zero or above on
arrays indicates some occupancy even tough there might not be
enrichment relative to genome average (see Figure 3A). Such signals
would be detected as positive by ChIP-qPCR, commonly expressed
asa percentofinput DNA. Negative levelsareincontrast indicative,
in the present study, of hypomethylation.
Trimethylation of H3K4 and H3K27 Delineates a Cell
Identity Profile in the ICM and TE
We have identified nearly three times as many H3K4/K27me3
promoters in the ICM as in the TE, suggesting that transcriptional
silencing mediated by Polycomb-mediated K27 trimethylation
[35] is more widespread in the ICM. This is in line with the
greater abundance of Polycomb proteins in the ICM than TE [5],
and with a requirement for the activation of a greater number of
genes to initiate embryonic development than placental differen-
tiation. H3K4me3 and H3K27me3 profiles in the ICM and TE
may thus reflect the developmental fate of these lineages. Although
the function of genes associated with H3K4/K27me3 promoters
largely overlaps between ICM, TE and ESCs, there is only partial
overlap of the target genes themselves. Thus each of these cell
types retains some identity despite all being undifferentiated, a
function suggested to be linked to the H3K27 methylase activity of
Ezh2 [36]. The distinct developmental fates of the ICM and TE
may speculatively be provided by the association of Ezh2 with
different repressor complexes in these lineages [37], which have at
least some non-redundant target genes. This possibility remains to
be investigated.
In the blastocyst, different types of chromatin marks are related
to the function of the associated genes rather than to a particular
cell type. In the ICM and TE, as in ESCs and progenitor cells
[10,16,17,28,38,39], H3K4me3 promoters belong to genes with
housekeeping functions, most of which are expressed. In contrast,
expression is attenuated by H3K27 methylation (82% of ICM
H3K27me3 genes are repressed), which targets signaling and
developmental genes. We found that ,50% of H3K4/K27me3
genes in the ICM are expressed, a figure higher than the few
percents of active H3K4/K27me3 genes in ESCs [11]. Thus
H3K4/K27me3 co-enrichment in undifferentiated cells in vivo is as
likely to mark active genes as repressed genes.
One of the earliest markers of epigenetic asymmetry between
the ICM and the TE is DNA hypermethylation in the ICM
[2,4,40]. DNA hypermethylation in the ICM parallels enrichment
of H3K27me3 in this compartment [5], suggesting that these
modifications contribute to the repression of developmentally-
regulated genes. A role of DNA methylation in maintaining the
embryonic lineage was shown to depend on methylation of the
TE-specific factor Elf5, whose expression is regulated by DNA
methylation, and which positively regulates Cdx2 and Eomes
expression [2]. Of note, we found that Elf5 is only trimethylated
on H3K4 in the TE, a state compatible with unmethylated DNA
and active transcription, whereas it harbors neither H3K4me3 nor
H3K27me3 in the ICM (where it is repressed), and in ESCs is
methylated only on H3K27 (data not shown), in addition to being
DNA methylated [2]. These observations highlight a role of DNA
methylation and histone modifications in regulation of lineage-
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nation in the embryo.
Dynamic Changes in H3K4 and H3K27 Methylation
Contribute to the ES Cell Epigenome
We show that epigenetic skewing takes place after derivation of
ESCs, indicating that ESCs are epigenetically distinct from the
ICM. This is evidenced by loss of, or reduction in, trimethylation
on H3K4 and H3K27 from the ICM on most promoters. Because
many cell divisions occur during ESC derivation, we cannot at
present invoke the role of an active demethylation process over a
lack of replication-coupled maintenance histone methylation.
However, there is also a gain of H3K4/K27me3 promoters in
ESCs which involves de novo K27 methylation preferentially over
K4 methylation. This greater dynamics of H3K27 methylation
changes reflects its importance in the regulation of complex
differentiation functions.
These observations raise the question of if ESCs are epigenet-
ically different from ICM cells, then how can one account for their
pluripotency in vivo? First, H3K4 and H3K27 methylation profiles
on genes associated with pluripotency are comparable in the ICM
and ESCs (this paper) [19]. Second, although ESCs can contribute
to chimeras and support full development, not all ESC cultures are
able to do so. This inefficiency may involve irreversible changes in
the epigenetic program of the cultured cells. Nevertheless,
chromatin states can be reversed through nuclear reprogramming.
Thus, alterations in epigenetic modifications, as evidenced upon
derivation of ESCs, may be reverted when the cells are placed in a
new environment, such as in the ICM of host embryos. The
predominance of H3K27 (relative to H3K4) methylation changes
after ESC derivation and in the developing embryo, together with
the association of H3K27me3-enriched genes with signaling and
developmental functions, argues in favor H3K27 (de)methylation
dynamics as an important component of the epigenetic plasticity of
embryos and undifferentiated cells.
Materials and Methods
Embryos, Cells and Antibodies
B6D2F2 embryos were collected at the two-cell stage from
superovulated and bred B6D2F1 (C57BL/6JxDBA/2) mice and
cultured for 3 days (4.5 days post-coitum) to the blastocyst stage [41].
Animal maintenance and experimentation were conformed to the
Guide for Care and Use of Laboratory Animals and were approved by the
Institutional Committee for Laboratory Animal Experimentation at
the RIKEN Kobe Institute. Females were superovulated with an
injection of 5 IU equine chorionic gonadotropin and 5 IU human
chorionic gonadotropin 48 h apart, bred to B6D2F1 males and
sacrificed at 1.5 days post-coitum to collect embryos. TEs were
isolated by bisection and ICMs purified by bisection and immuno-
surgery [42]. We collected in this manner 317 purified ICMs which
were pooled, and 352 TEs which were also pooled. This provided
chromatin for 6 ChIPs from ICMs, and 6 ChIPs from TEs. B6D2F2
ESCs were derived and cultured without feeders [41] to passage 8.
ESCs were characterized previously [43] and shown to be germ-line
competent (our unpublished data). Antibodies to H3K4me3 (cat#
Ab8580) and H3K27me3 (cat# 05-851) were from Abcam (Cam-
bridge, UK, http://www.abcam.com) and Upstate (Charlottesville,
VA, http://www.upstate.com), respectively.
Ethics Statement
Protocols for animal handling and treatment were reviewed and
approved by the Institutional Committee for Laboratory Animal
Experimentation at the RIKEN Kobe Institute.
Chromatin Immunoprecipitation
mChIP was done as described [22] from isolated ICMs and TEs.
In short, 2.4 mg antibody was coupled to 10 ml Dynabeads Protein
A (Invitrogen, Oslo, Norway; http://www.invitrogen.com) in RIPA
buffer (10 mM Tris-HCl pH 7.5, 140 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 0.1% SDS, 0.1% Na-deoxycholate). ICMs and TEs
were cross-linked in PBS/20 mM Na butyrate containing 1%
formaldehyde for 8 min and quenched with 125 mM glycine.
Samples were frozen in liquid nitrogen and stored at 280uC. Lysis
buffer (50 mM Tris-HCl, pH 8, 10 mM EDTA, 1% SDS, protease
inhibitor cocktail, 1 mM PMSF, 20 mM butyrate) was added to
,200 ml to each frozen sample before pooling using siliconized
pipette tips. Lysed cells were sonicated for 3630 sec on ice with 30
sec pauses using a probe sonicator (Labsonic-M, 3-mm probe; cycle
0.5, 30%power;SartoriusAG,Goettingen,Germany,http://www.
sartorius.com) to produce ,400–500 bp chromatin fragments.
Fragment size was assessed by quantitative (q)PCR as recently
described [23]. RIPA buffer (300 ml, with protease inhibitors, 1 mM
PMSF, 20 mM butyrate) was added, samples centrifuged at 12,000
g and 450 ml supernatant was transferred into a 1.5 ml tube.
Another 450 ml RIPA buffer was added to the sedimented lysate,
centrifugation was repeated and 490 ml supernatant was pooled
with the first one. RIPA buffer was added to the pooled
supernatants to 1.22 ml, and 200 ml aliquots were transferred into
six tubes containing antibody-coated beads.
Beads were released into chromatin and rotated at 40 rpm for 2
ha t4 uC. ChIP material was washed three times in 100 ml RIPA
and once in 100 ml TE buffer, and transferred into a new tube
while in TE. Elution buffer and 5 mg RNase were added after
removal of TE. Samples were incubated at 37uC for 20 min on a
thermomixer. Proteinase K (1 mla t2 0 mg/ml) was added and
DNA elution, cross-link reversal and protein digestion were
carried out for 2 h at 68uC on a thermomixer followed by a
second extraction for 5 min; both supernatants were pooled. ChIP
samples were made up to 490 ml in elution buffer without SDS.
ChIP DNA was purified by phenol-chloroform isoamylalcohol
extraction, ethanol-precipitated with 10 ml acrylamide carrier and
dissolved in 10 ml MilliQ water.
ChIP and input DNA were amplified using the WGA4
GenomePlex Whole Genome Amplification Kit (Sigma-Aldrich,
St. Louis, MO, http://www.sigma-aldrich.com) omitting lysis and
DNA fragmentation steps. DNA was cleaned up (QIAquick kit,
Qiagen, Valencia, CA, http://www.qiagen.com), purified and
diluted to 250–500 ng/ml in MilliQ water.
To establish the specificity of H3K4me3 and H3K27me3
enrichment, duplicate total H3 ChIPs were performed using an
anti-H3 antibody (Abcam; cat# ab1791) precipitating any
modified form of H3. As anticipated from precipitation of a
widely distributed core histone, ,80% of input DNA was
precipitated under these conditions and hybridization to promoter
arrays showed low or no enrichment over genome-average, with
only 470 peaks detected in both replicates (data not shown).
Moreover, four negative control ChIPs with a pre-immune rabbit
IgG (Millipore, cat# PP64B; http://www.millipore.com) only
precipitated minute amounts of DNA; these were estimated by
spectrophotometry to represent ,0.3% of input DNA and were
essentially not detectable by qPCR (data not shown).
Microarray Hybridization and Data Analysis
ChIP and input DNA fragments were labeled with Cy5 and Cy3,
respectively, and co-hybridized on Roche Nimblegen (Madison,
WI, http://www.nimblegen.com) MM8 RefSeq Promoter arrays
covering ,27,000 promoters including 19,489 RefSeq promoters,
ranging from 22,000 to +500 bp relative to the transcription start
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custom-written software. Peaks were detected by searching for four
or more probes with a signal above a cut-off value using a 500-bp
sliding window. Cut-off values were a percentage of a hypothetical
maximum defined as (mean + 6[standard deviation]). log2 ChIP/
Input ratio data were randomized 20 times to evaluate the
probability of false positives, and each peak was assigned a false
discovery rate (FDR) score. Normalization and peak detection were
performed by Nimblegen according to their published protocols.
Thisprocessusesacut-offrangeof90%to15%,with highercut-offs
corresponding to more stringent peak detection, reflected in the
FDR calculation. H3K4me3- and H3K27me3 enrichment was
identified based on detection of at least one peak at FDR#0.1 in
both replicates (N=2) or in two of three replicates (N=3).
For scoring promoters for correlation analysis we assigned an
amplification value to each promoter by applying the Maxfour
algorithm with a 10-probe window [45] (MaxTen). For each
promoter, the corresponding probes log2 ratios were scanned in
genome order with a 10-probe window. The highest 10-probe
average was used as the amplification value for the promoter.
Averaged MaxTen values from two ChIP replicates for each cell
type are reported.
Assembly of a metagene of histone modification enrichment was
performed [23] using genes with identified peaks. For metagene
analysis, we identified ‘null-peak’ tiled regions as those having all
probe ratios below the minimal cut-off value for peak detection.
The microarray data have been deposited in a MIAME compliant
database and are available in the NCBI GEO database under
accession number GSE17387.
GO terms were either identified for all genes in a particular set, or
GO term enrichments within a target gene set were calculated. We
calculated GO term enrichments using the GOstats package [46].
GOstats identifies functional terms for selected genes and provides a
significance of enrichment for a term by producing a P-value
indicating the probability that the identified term is enriched to a
greater extent among the target genes than would be expected by
chance, based on the number of genes in the genome that belong to
this term. GO term identifications for all genes were computed using
GO mapping (ftp://ftp.ncbi.nih.gov/gene/DATA/gene2go.gz).
Analysis of Gene Expression from Affymetrix Arrays
The 15,941 cDNAs included in a published Affymetrix
expression data set for 20 single ICM cells (NCBI GEO
GSE4307) [27] were analyzed for histone methylation patterns.
For each probe on the Affymetrix array, we derived a present/
absent call by scoring ‘present’ if a signal was detected in ten or
more of the 20 samples analyzed, in agreement with the method
used to collapse replicates by DNA Chip Analyzer [29].
Expression array data have been deposited in a MIAME
compliant database and are available in the NCBI GEO database
under accession number GSE17387.
Quantitative PCR
ChIP DNA was also analyzed by duplicate qPCR as
described[22] using the following primers: Hhex, (F) tcccccgttcta-
gacagt, (R) agcctctggaacctgga; Nanog, (F) ctatcgccttgagccgttg, (R)
aactcagtgtctagaaggaaagatca; Pou5f1/Oct4, (F) ctgtaaggacaggccga-
gag, (R) caggaggccttcattttcaa. Annealing temperature was 60uC for
all primer pairs.
Supporting Information
Figure S1 Isolated ICMs and TEs are viable. (A) Separation of
ICMs and TEs by bisection, as also shown in Figure 1A. (B,C)
Three hours after bisection, ICMs recavitate to form new
blastocysts (B) and TEs recavitate to form trophoblastic vesicles
(C).
Found at: doi:10.1371/journal.pone.0009150.s001 (0.28 MB
DOC)
Figure S2 Validation and reproducibility of mChIP-chip. (A) 2-
D scatter plots of MaxTen values for H3K4me3 and H3K27me3
log2 signal intensities detected by Q
2ChIP vs. mChIP in mouse P19
embryonal carcinoma cells. Correlation coefficient (R) and
regression line are shown. (B) 2-D scatter plots of MaxTen values
for H3K4me3 replicate and H3K27me3 replicate log2 signal
intensities detected by Q
2ChIP (top graphs) and mChIP (bottom
graphs). (C) Average H3K4me3 and H3K27me3 enrichment
profiles on promoters, detected by Q
2ChIP and mChIP. TSS is
represented by a red bar. (D) H3K4me3 and H3K27me3 profiles
detected by Q
2ChIP and mChIP on promoters through 520 kb of
mouse chromosome 7. Data are expressed as log2 ChIP/input
ratios. Position of transcripts is shown as black bars on the mRNA
track.
Found at: doi:10.1371/journal.pone.0009150.s002 (0.16 MB TIF)
Figure S3 Enrichment of H3K4me3 and H3K27me3 in the
ICM and TE (two replicates each) expressed as log2 ChIP/input
ratios (y axes) over 220 kb of chromosome 17.
Found at: doi:10.1371/journal.pone.0009150.s003 (0.08 MB TIF)
Figure S4 mChIP-chip H3K4me3 and H3K27me3 enrichment
profiles in ESCs. (A) Enrichment profile across the Hoxb locus. (B)
Enrichment profiles on indicated promoters. (C) GO term
enrichment of genes with a promoter enriched in indicated
histone modifications.
Found at: doi:10.1371/journal.pone.0009150.s004 (0.20 MB TIF)
Table S1 GO terms enriched for genes with promoters
containing H3K4me3, H3K27me3, both marks or none of the
marks in the ICM and TE (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s005 (0.07 MB
XLS)
Table S2 GO terms associated with all H3K4/K27me3
promoter-containing genes identified in the ICM and TE (Excel
file).
Found at: doi:10.1371/journal.pone.0009150.s006 (0.08 MB
XLS)
Table S3 GO terms associated with all expressed H3K4me3,
H3K27me3 and H3K4/K27me3 promoter-containing genes in
the ICM (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s007 (0.20 MB
XLS)
Table S4 GO terms enriched for expressed H3K4me3,
H3K27me3 and H3K4/K27me3 promoter-containing genes in
the ICM (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s008 (0.03 MB
XLS)
Table S5 X-linked genes enriched in H3K27me3 in the TE
(Excel file).
Found at: doi:10.1371/journal.pone.0009150.s009 (0.02 MB
XLS)
Table S6 GO terms enriched for genes with promoters
containing H3K4me3, H3K27me3, both marks, or none of these
marks in ESCs (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s010 (0.06 MB
XLS)
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genes with promoters containing H3K4me3, H3K27me3 or both
marks (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s011 (0.12 MB
XLS)
Table S8 GO terms and list of genes enriched in H3K4/
K27me3 in the ICM only or in ESCs only (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s012 (0.29 MB
XLS)
Table S9 GO terms and list of genes enriched in H3K4/
K27me3 in the ICM only or in the TE only (Excel file).
Found at: doi:10.1371/journal.pone.0009150.s013 (0.11 MB
XLS)
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